Product Images Kymriah

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Kymriah NDC 0078-0958 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Note: The patient identifier number may be preceded by the letters DIN or Aph ID. - kymriah 01

Note: The patient identifier number may be preceded by the letters DIN or Aph ID. - kymriah 01

PRINCIPAL DISPLAY PANELtisagenlecleucelKYMRIAHtmNDC 0078-0846-19Human T cellsRx only Suspension for IV infusionCultured, genetically modifiedFor autologous use onlyDispense with Medication GuideNovartis - kymriah 02

PRINCIPAL DISPLAY PANELtisagenlecleucelKYMRIAHtmNDC 0078-0846-19Human T cellsRx only Suspension for IV infusionCultured, genetically modifiedFor autologous use onlyDispense with Medication GuideNovartis - kymriah 02

This is a medication called Tisagenlecleucel Himentes, available in suspended form for intravenous infusion use. It is genetically modified and exclusively meant for autologous use only. One bag can contain 10-50mL of the total volume. It is cryopreserved and needs to be stored at very low temperatures. This medication is not evaluated for infectious substances and has instructions not to use a leukocyte-depleting filter or irradiate it. The manufacturer is Novartis Pharmaceuticals Corporation, and for details, their website KYMRIAH.com should be visited. The package needs to be dispensed with the medication guide. The provided number can be called for further information or in case of any query. There is no information on this text about the actual use of this medication.*

kymriah 03

kymriah 03

This is a medication called OKYMRIAH, with the generic name Tisagenlecleucel. It is a suspension for intravenous infusion and requires a medication guide for dispensing. The dosage is to be determined based on the prescription provided. It is packaged in bags with a volume of 10mL-50mL. It is cryopreserved using several substances, including T cells. The medication is to be stored at <-120°C and is manufactured by Novartis Pharmaceuticals Corporation. The product is not evaluated for infectious substances, and caution is advised while administering the medication.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.